SG Americas Securities, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 182 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$119
-56.7%
36,372
-2.9%
0.00%0.0%
Q1 2024$275
-18.9%
37,456
-58.6%
0.00%
-66.7%
Q4 2023$339
+117.3%
90,553
+23.0%
0.00%
+50.0%
Q3 2023$156
+147.6%
73,642
+569.5%
0.00%
+100.0%
Q1 2023$63
-100.0%
11,000
-15.9%
0.00%
-66.7%
Q2 2022$324,000
-92.0%
13,076
-87.5%
0.00%
-90.0%
Q1 2022$4,059,000
-83.5%
104,705
-75.1%
0.03%
-77.6%
Q4 2021$24,585,000
+632.6%
420,190
+642.2%
0.13%
+737.5%
Q3 2021$3,356,000
-27.1%
56,614
+6.7%
0.02%
-23.8%
Q2 2021$4,606,000
+215.7%
53,071
+199.9%
0.02%
+162.5%
Q1 2021$1,459,000
+456.9%
17,699
+514.8%
0.01%
+700.0%
Q4 2020$262,000
-91.5%
2,879
-96.3%
0.00%
-95.0%
Q3 2020$3,089,000
+1945.7%
77,271
+1651.8%
0.02%
+1900.0%
Q2 2020$151,000
-73.3%
4,411
-82.7%
0.00%
-80.0%
Q1 2020$565,000
+234.3%
25,435
+163.9%
0.01%
+150.0%
Q1 2019$169,000
+302.4%
9,637
-9.1%
0.00%
Q3 2017$42,00010,5960.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$11,083,3302.77%
Redmile Group, LLC 13,169,057$43,194,5072.61%
SUPERSTRING CAPITAL MANAGEMENT LP 497,360$1,631,3412.06%
Boxer Capital, LLC 8,215,910$26,948,1851.42%
Deep Track Capital, LP 5,572,607$18,278,1510.55%
Vestal Point Capital, LP 2,000,000$6,560,0000.49%
Bruce & Co., Inc. 300,000$984,0000.32%
Octagon Capital Advisors LP 520,800$1,708,2240.27%
Integral Health Asset Management, LLC 850,000$2,788,0000.26%
Bellevue Group AG 4,839,779$15,874,4750.26%
View complete list of FATE THERAPEUTICS INC shareholders